Hierarchical Autophagy Selectivity as a Metabolic Rheostat: Disruption of Organelle‑Protein Degradation Order Drives Inflammaging via Mitochondrial DAMP Release

Background

Autophagy functions as a selective, hierarchical cannibalism system where cargo receptors, ubiquitin chain topology, and nutrient‑sensing pathways determine which substrates are degraded first 1. Mitochondrial quality control exemplifies this hierarchy: structural damage engages the PINK1/Parkin route, while metabolic impairment triggers BNIP3/BNIP3L‑mediated mitophagy, a process restrained by the PPTC7/SCF^FBXL4 complex until a threshold is crossed 2 3. NAD+ depletion acts as a upstream signal that reprograms the degradation queue via mTORC1 and PI3K inhibition 4. Furthermore, autophagy contributes roughly one‑third of mitochondrial protein turnover in a protein‑selective manner, allowing nibbling of specific proteins rather than whole organelles 5.

Hypothesis

We propose that the order in which autophagy degrades mitochondrial constituents—not the overall flux—acts as a metabolic rheostat that preserves cellular homeostasis. When the hierarchical sequence is perturbed (e.g., premature degradation of matrix proteins before removal of damaged membranes or selective loss of respiratory‑chain subunits while retaining oxidant‑producing complexes), mitochondria release specific damage‑associated molecular patterns (DAMPs) that activate inflammasome signaling and drive sterile inflammation characteristic of aging.

Mechanistic Insight

1. Priority Queue Model – Cargo receptors such as NIX/BNIP3L and autophagy adaptors (p62, NDP52) bind distinct ubiquitin chain topologies (K63 vs K48) and ATG8 proteins, establishing a molecular priority queue. Under normal conditions, K63‑linked ubiquitin on outer‑membrane proteins recruits BNIP3/BNIP3L first, leading to limited mitophagy that preserves inner‑membrane integrity. Only after metabolic stress surpasses a threshold does PPTC7 inhibition allow K48‑linked ubiquitination of matrix proteins, triggering their selective degradation.
2. Disruption Consequences – Genetic or pharmacological manipulation that alters the ubiquitin chain bias (e.g., overexpressing a K63‑specific deubiquitinase or inhibiting PPTC7) reverses the order: matrix proteins are degraded while the outer membrane remains intact. This yields mitochondria with intact outer membranes but compromised matrix, favoring leakage of mitochondrial DNA and formylated peptides without efficient removal of the organelle, thereby potentiating cGAS‑STING and NLRP3 activation.
3. NAD+ Link – Declining NAD+ shifts the queue toward bulk autophagy, bypassing the selective hierarchy and causing non‑discriminatory organelle consumption. This accelerates loss of functional mitochondria while sparing damaged ones, amplifying DAMP release.

Testable Predictions

• Prediction 1: Cells expressing a ubiquitin‑chain‑biased mutant of p62 that favors K48 over K63 linkages will show increased matrix protein degradation (measured by mitochondrial proteomics) concomitant with elevated cytosolic mtDNA and IL‑1β release compared with wild‑type controls.
• Prediction 2: Pharmacological activation of PPTC7 (e.g., with a small‑molecule activator) in aged mice will restore the normal degradation order (outer‑membrane before matrix), reduce mitochondrial DAMP signaling, and improve tissue‑specific inflammaging markers (serum IL‑6, NLRP3 inflammasome activity).
• Prediction 3: Inducing NAD+ depletion via PARP overactivation will disrupt the hierarchical sequence, leading to a shift from selective mitophagy to bulk autophagy and a concomitant rise in inflammasome activation; rescuing NAD+ with NR supplementation should reestablish the selective order and dampen inflammation.

Experimental Approach

1. In vitro: Generate CRISPR‑edited HEK293T lines expressing ubiquitin‑chain‑specific p62 mutants. Measure mitochondrial protein turnover using SILAC‑based proteomics after starvation, assess mtDNA in the cytosol by qPCR, and quantify inflammasome activation via caspase‑1 cleavage and IL‑1β ELISA.
2. In vivo: Treat aged (20‑month) C57BL/6 mice with a PPTC7 activator or vehicle for 8 weeks. Isolate liver and muscle mitochondria to evaluate ubiquitin‑chain patterns on outer‑ vs inner‑membrane proteins (immunoblot with linkage‑specific antibodies). Monitor circulating cytokines and perform histology for inflammasome activation (ASC speck formation).
3. Metabolic modulation: Use PARP1‑overexpressing mice to induce NAD+ depletion, administer NR, and repeat the above assays to test whether NAD+ restoration rescues the hierarchical degradation order.

Implications

If validated, this hypothesis reframes autophagy dysregulation in aging not as a simple loss of flux but as a mis‑ordered selective process. It suggests therapeutic strategies that target the priority of autophagic cargo (e.g., modulating ubiquitin chain editors or PPTC7 activity) could preserve mitochondrial fidelity and mitigate inflammaging without globally altering autophagy levels.